Sherman Jeffrey Scott, CFO of NeoGenomics Inc. ($NEO), made two open market purchases of company shares totaling $262 thousand over the past year, with his most recent buy on August 6, 2025. His activity ranks 1,260th among 4,983 insiders by purchase value, below the average of $1.5 million across 3.29 transactions per insider. He reported no open market sales in the last 365 days.
| Transaction Date | Company | Ticker | Insider Name | Title | Transaction Type | Security | Shares | Price | Shares Owned Following | Total Shares Outstanding | % of Owned | % of Outstanding |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Feb. 23, 2026 | NEOGENOMICS INC | $NEO | Sherman Jeffrey Scott | Chief Financial Officer | M | Common Stock | 15535 | $0.00 | 223,792.0000 | 129,812,211 | 7.46% | 0.01% |
| Feb. 23, 2026 | NEOGENOMICS INC | $NEO | Sherman Jeffrey Scott | Chief Financial Officer | M | Restricted Stock Unit | 15535 | $0.00 | 87,924.0000 | 129,812,211 | 15.02% | 0.01% |
| Feb. 21, 2026 | NEOGENOMICS INC | $NEO | Sherman Jeffrey Scott | Chief Financial Officer | M | Restricted Stock Unit | 42158 | $0.00 | 156,706.0000 | 129,812,211 | 21.20% | 0.03% |
| Feb. 23, 2026 | NEOGENOMICS INC | $NEO | Sherman Jeffrey Scott | Chief Financial Officer | F | Common Stock | 3783 | $0.00 | 220,009.0000 | 129,812,211 | 1.69% | 0.00% |
| Feb. 21, 2026 | NEOGENOMICS INC | $NEO | Sherman Jeffrey Scott | Chief Financial Officer | M | Common Stock | 42158 | $0.00 | 218,986.0000 | 129,812,211 | 23.84% | 0.03% |
| Feb. 21, 2026 | NEOGENOMICS INC | $NEO | Sherman Jeffrey Scott | Chief Financial Officer | F | Common Stock | 10729 | $0.00 | 208,257.0000 | 129,812,211 | 4.90% | 0.01% |
| Dec. 7, 2025 | NEOGENOMICS INC | $NEO | Sherman Jeffrey Scott | Chief Financial Officer | F | Common Stock | 11938 | $0.00 | 176,394.0000 | 129,387,801 | 6.34% | 0.01% |
| Aug. 6, 2025 | NEOGENOMICS INC | $NEO | Sherman Jeffrey Scott | Chief Financial Officer | P | Common Stock | 20000 | $5.62 | 188,332.0000 | 128,461,383 | 11.88% | 0.02% |
| May 11, 2025 | NEOGENOMICS INC | $NEO | Sherman Jeffrey Scott | Chief Financial Officer | M | Common Stock | 13005 | $0.00 | 171,499.0000 | 128,461,383 | 8.21% | 0.01% |
| May 11, 2025 | NEOGENOMICS INC | $NEO | Sherman Jeffrey Scott | Chief Financial Officer | F | Common Stock | 3167 | $0.00 | 168,332.0000 | 128,461,383 | 1.85% | 0.00% |
| May 11, 2025 | NEOGENOMICS INC | $NEO | Sherman Jeffrey Scott | Chief Financial Officer | M | Restricted Stock Unit | 13005 | $0.00 | 229,935.0000 | 128,461,383 | 5.35% | 0.01% |
| May 2, 2025 | NEOGENOMICS INC | $NEO | Sherman Jeffrey Scott | Chief Financial Officer | P | Common Stock | 20000 | $7.51 | 158,494.0000 | 128,461,383 | 14.44% | 0.02% |
| Feb. 23, 2025 | NEOGENOMICS INC | $NEO | Sherman Jeffrey Scott | Chief Financial Officer | M | Common Stock | 15535 | $0.00 | 141,271.0000 | 128,461,383 | 12.36% | 0.01% |
| Feb. 21, 2025 | NEOGENOMICS INC | $NEO | Sherman Jeffrey Scott | Chief Financial Officer | A | Stock Option (Right to Buy) | 214900 | $0.00 | 292,813.0000 | 128,461,383 | 275.82% | 0.17% |
| Feb. 21, 2025 | NEOGENOMICS INC | $NEO | Sherman Jeffrey Scott | Chief Financial Officer | A | Restricted Stock Unit | 126476 | $0.00 | 211,869.0000 | 128,461,383 | 148.11% | 0.10% |
| Feb. 23, 2025 | NEOGENOMICS INC | $NEO | Sherman Jeffrey Scott | Chief Financial Officer | M | Restricted Stock Unit | 15535 | $0.00 | 116,464.0000 | 128,461,383 | 11.77% | 0.01% |
| Feb. 23, 2025 | NEOGENOMICS INC | $NEO | Sherman Jeffrey Scott | Chief Financial Officer | F | Common Stock | 4207 | $0.00 | 137,064.0000 | 128,461,383 | 2.98% | 0.00% |
| Jan. 14, 2025 | NEOGENOMICS INC | $NEO | Sherman Jeffrey Scott | Chief Financial Officer | A | Restricted Stock Unit | 59382 | $0.00 | 131,999.0000 | 0 | 81.77% | 0.00% |
| Dec. 7, 2024 | NEOGENOMICS INC | $NEO | Sherman Jeffrey Scott | Chief Financial Officer | F | Common Stock | 11746 | $0.00 | 123,754.0000 | 0 | 8.67% | 0.00% |
| May 11, 2024 | NEOGENOMICS INC | $NEO | Sherman Jeffrey Scott | Chief Financial Officer | F | Common Stock | 3167 | $14.86 | 135,500.0000 | 0 | 2.28% | 0.00% |
| May 11, 2024 | NEOGENOMICS INC | $NEO | Sherman Jeffrey Scott | Chief Financial Officer | M | Restricted Stock Unit | 13005 | $0.00 | 26,011.0000 | 0 | 33.33% | 0.00% |
| May 11, 2024 | NEOGENOMICS INC | $NEO | Sherman Jeffrey Scott | Chief Financial Officer | M | Common Stock | 13005 | $0.00 | 138,667.0000 | 0 | 10.35% | 0.00% |
| May 11, 2024 | NEOGENOMICS INC | $NEO | Sherman Jeffrey Scott | Chief Financial Officer | M | Restricted Stock Unit | 13005 | $0.00 | 72,617.0000 | 0 | 15.19% | 0.00% |
| May 11, 2024 | NEOGENOMICS INC | $NEO | Sherman Jeffrey Scott | Chief Financial Officer | M | Common Stock | 13005 | $0.00 | 138,667.0000 | 0 | 10.35% | 0.00% |
| May 11, 2024 | NEOGENOMICS INC | $NEO | Sherman Jeffrey Scott | Chief Financial Officer | F | Common Stock | 3167 | $14.86 | 135,500.0000 | 0 | 2.28% | 0.00% |
| May 11, 2024 | NEOGENOMICS INC | $NEO | Sherman Jeffrey Scott | Chief Financial Officer | M | Common Stock | 13005 | $0.00 | 148,505.0000 | 0 | 9.60% | 0.00% |
| Feb. 23, 2024 | NEOGENOMICS INC | $NEO | Sherman Jeffrey Scott | Chief Financial Officer | A | Performance Stock Unit | 46606 | $0.00 | 85,622.0000 | 0 | 119.45% | 0.00% |
| Feb. 23, 2024 | NEOGENOMICS INC | $NEO | Sherman Jeffrey Scott | Chief Financial Officer | A | Restricted Stock Unit | 46606 | $0.00 | 85,622.0000 | 0 | 119.45% | 0.00% |
| Feb. 23, 2024 | NEOGENOMICS INC | $NEO | Sherman Jeffrey Scott | Chief Financial Officer | A | Stock Option (Right to Buy) | 77913 | $0.00 | 77,913.0000 | 0 | 9999.99% | 0.00% |